Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 24 Kidney Neoplasms 10 Neoplasms 9 Carcinoma 6 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Carcinoma, Non-Small-Cell Lung 4 Recurrence 3 Neoplasm Metastasis 3 Melanoma 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Lung Neoplasms 2 Kidney Diseases 2 Glioblastoma 2 Carcinoma, Adenoid Cystic 2 Breast Neoplasms 2 Advanced Solid Tumors 2 cT2a N0NxM0 Renal Tumor 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solitary Fibrous Tumors 1 Solid Tumors 1 Solid Malignancies 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Refractory or Recurrent Solid Tumors, Excluding CNS Tumors 1 Prostatic Neoplasms 1

Interventions

Cetuximab 11 Cisplatin 10 Radiotherapy 8 Docetaxel 8 Erlotinib Hydrochloride 7 Paclitaxel 6 Gemcitabine 6 Chemotherapy, Adjuvant 6 Immunohistochemistry 5 Sorafenib 4 Radiosurgery 4 Carboplatin 4 Capecitabine 4 Biopsy 4 sargramostim 3 Vorinostat 3 Trastuzumab 3 Surgical Procedures, Operative 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 3 Lapatinib 3 Irinotecan 3 Filgrastim 3 Doxorubicin 3 Bevacizumab 3 ixabepilone 2 aldesleukin 2 Taxes 2 SS1(dsFv)PE38 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Salivary Gland Neoplasms × Axitinib × Clear all

NCT02857712 2019-08-30

SGC-AX14

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed

Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡